Janux Therapeutics Ownership | Who Owns Janux Therapeutics?

Overview Forecast RevenueFinancials Chart

Janux Therapeutics Ownership Summary

Janux Therapeutics is owned by 105.71% institutional investors, 6.59% insiders. Ra capital management is the largest institutional shareholder, holding 18.08% of JANX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.67% of its assets in Janux Therapeutics shares.

JANX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Janux Therapeutics	105.71%	6.59%	-12.30%
Sector	Healthcare Stocks	487.91%	11.08%	-398.99%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	11.19M	18.08%	$258.48M
Fmr	8.67M	15.87%	$464.19M
Janus henderson group	3.56M	6.52%	$190.62M
Blackrock funding, inc. /de	3.40M	5.50%	$78.61M
Paradigm biocapital advisors lp	3.33M	5.39%	$89.91M
Blackrock	2.34M	4.78%	$98.19M
Adage capital partners gp	2.52M	4.08%	$58.33M
Vanguard group	2.14M	3.91%	$114.38M
Point72 asset management	2.14M	3.46%	$49.52M
Woodline partners lp	1.85M	3.39%	$99.17M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Prosight management, lp	853.90K	4.81%	$19.73M
Ra capital management	11.19M	4.35%	$258.48M
Paradigm biocapital advisors lp	3.33M	4.12%	$89.91M
Ecor1 capital	1.47M	2.98%	$78.69M
Cormorant asset management, lp	1.50M	2.58%	$34.65M
Logos global management lp	1.00M	2.56%	$23.10M
Bioimpact capital	614.28K	2.46%	$14.19M
First turn management	430.16K	2.34%	$11.61M
Orbimed advisors	1.21M	0.70%	$27.96M
Woodline partners lp	1.85M	0.67%	$99.17M

Top Buyers

Holder	Shares	% Assets	Change
Point72 asset management	2.14M	0.10%	1.77M
Janus henderson group	3.56M	0.10%	1.04M
Holocene advisors, lp	1.02M	0.17%	1.02M
State street	1.40M	0.00%	1.00M
Price t rowe associates inc /md/	1.11M	0.01%	950.56K

Top Sellers

Holder	Shares	% Assets	Change
Adage capital partners gp	2.52M	0.10%	-1.13M
Rtw investments, lp	-	-	-1.00M
Perceptive advisors	292.69K	0.25%	-677.73K
Lord, abbett	-	-	-667.88K
Logos global management lp	1.00M	2.56%	-650.00K

New Positions

Holder	Shares	% Assets	Change	Value
Holocene advisors, lp	1.02M	0.17%	1.02M	$54.35M
Trexquant investment lp	65.86K	0.04%	65.86K	$3.53M
Congress asset management co /ma	55.77K	0.01%	55.77K	$1.36M
Ghost tree capital	50.00K	0.66%	50.00K	$2.09M
Tig advisors	42.59K	0.16%	42.59K	$2.28M

Sold Out

Holder	Change
National bank of canada /fi/	-1.00
Quantbot technologies lp	-1.00
Parallel advisors	-7.00
Signaturefd	-9.00
Corecap advisors	-9.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	180	-6.25%	65,438,049	-1.58%	105	0.91%	93	-21.19%	53	23.26%
Mar 31, 2025	7	-96.93%	3,447,727	-94.63%	5	0.04%	5	-96.82%	1	-97.73%
Dec 31, 2024	213	29.09%	61,331,550	34.45%	112	1.61%	149	67.42%	37	-22.92%
Sep 30, 2024	164	2.50%	45,609,396	2.07%	83	1.24%	88	-20.00%	48	45.45%
Jun 30, 2024	159	28.23%	44,686,120	5.66%	91	0.99%	109	26.74%	33	17.86%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	2.20M	3.67%	2.89K
Fidelity Growth Compy Commingled Pl O	1.65M	3.16%	20.65K
Fidelity Growth Company Fund	1.56M	2.60%	-9.34K
Vanguard Total Stock Mkt Idx Inv	1.18M	1.98%	-26.09K
Vanguard US Total Market Shares ETF	1.00M	1.69%	193.50K
iShares Russell 2000 ETF	945.98K	1.57%	-
Fidelity Select Health Care	699.39K	1.16%	-
Fidelity Small Cap Growth	696.57K	1.16%	-
US Small-Cap Growth II Equity Comp	609.99K	1.03%	143.97K
SPDR® S&P Biotech ETF	571.67K	0.95%	1.27K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 01, 2025	Meyer Andrew Hollman	Chief Business Officer	Sell	$13.04K
May 01, 2025	Meyer Andrew Hollman	Chief Business Officer	Sell	$93.70K
Apr 21, 2025	Meyer Andrew Hollman	Chief Business Officer	Sell	$100.02K
Mar 06, 2025	RA CAPITAL MANAGEMENT, L.P.		Buy	$11.45M
Mar 05, 2025	RA CAPITAL MANAGEMENT, L.P.		Buy	$1.17M

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	3
2025 Q1	4	11
2024 Q4	1	23
2024 Q3	-	33
2024 Q2	-	8

JANX Ownership FAQ

Who Owns Janux Therapeutics?

Janux Therapeutics shareholders are primarily institutional investors at 105.71%, followed by 6.59% insiders and -12.30% retail investors. The average institutional ownership in Janux Therapeutics's industry, Biotech Stocks , is 307.10%, which Janux Therapeutics falls below.

Who owns the most shares of Janux Therapeutics?

Janux Therapeutics’s largest shareholders are Ra capital management (11.19M shares, 18.08%), Fmr (8.67M shares, 15.87%), and Janus henderson group (3.56M shares, 6.52%). Together, they hold 40.47% of Janux Therapeutics’s total shares outstanding.

Does Blackrock own Janux Therapeutics?

Yes, BlackRock owns 4.78% of Janux Therapeutics, totaling 2.34M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 98.19M$. In the last quarter, BlackRock increased its holdings by 650.02K shares, a 38.37% change.

Who is Janux Therapeutics’s biggest shareholder by percentage of total assets invested?

Prosight management, lp is Janux Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.81% of its assets in 853.9K Janux Therapeutics shares, valued at 19.73M$.

Who is the top mutual fund holder of Janux Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Janux Therapeutics shares, with 3.67% of its total shares outstanding invested in 2.2M Janux Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools